Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Medical Pharmaceutical Supply and Distribution

Active

Federal

Response Deadline07/28/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract is for the supply and delivery of FDA-regulated Lidocaine Hydrochloride and Epinephrine (USP) in 1.7 mL cartridges, packaged 50 per unit, to Joint Base Elmendorf-Richardson, Alaska, under the National Stock Number 6505-01-576-2767. The product must meet all federal pharmaceutical standards and be delivered under FOB Destination terms, ensuring the vendor assumes responsibility for transportation and risk until the goods reach the指定 location. The contract is classified as a subcontract within the NAICS code 325412 for pharmaceutical preparation manufacturing, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. Responses are required by July 28, 2026, with the solicitation posted on July 22, 2026, indicating a narrow six-day window for submissions. The place of performance is clearly identified as JBER with ZIP code 99506-4400, and all deliveries must align with military supply specifications. The contract is managed through the DLA Dibbs platform, requiring vendors to engage through the official portal to submit proposals. There is no set-aside designation specified, meaning all eligible contractors may compete without restrictions based on business size or category.

General Info

Supply of FDA-compliant Lidocaine-Epinephrine cartridges to Joint Base Elmendorf-Richardson under DLA Dibbs by July 28, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

JBER, AK, 99506-4400, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 22

subcontract

Response DeadlineJul 28

Submission deadline

Response Deadline

07/28/2026, 05:00:00 PM UTCin 5 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supply and delivery of FDA-regulated Lidocaine Hydrochloride and Epinephrine (USP) in 1.7 mL cartridges (50 per package) to Joint Base Elmendorf-Richardson, Alaska, compliant with NSN 6505-01-576-2767 and FOB Destination terms.

Similar Contracts

Same NAICS industry code

Medical Supply Procurement – Spinal Anesthesia Kits with PharmaceuticalsThe contract seeks the supply of pre-packaged spinal anesthesia kits, each containing a 25-gauge by 3.5-inch Quincke-type spinal needle and bupivacaine, fully compliant with FDA manufacturing, labeling, and packaging standards. The kits must be produced and assembled to meet stringent medical and regulatory requirements to ensure safety, sterility, and consistency for clinical use. All components must be integrated into a single, ready-to-use system designed for reliable performance in surgical settings, with labeling that clearly identifies contents, batch information, expiration dates, and usage instructions in accordance with federal guidelines. The procurement is issued as a subcontract under the Department of Defense's Medical Supply Chain, specifically managed by the MEDICAL SUPPLY CHAIN MD SURG FSF, with performance required at the Hampton, Virginia location identified by zip code 23665-2040. The solicitation, posted on July 22, 2026, has a response deadline of July 28, 2026, and falls under NAICS code 325412 for pharmaceutical and medicine manufacturing. Suppliers must be prepared to meet military-grade logistics and quality control expectations, with an emphasis on timely delivery, traceability, and full compliance with defense procurement protocols.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supplier of Hydrogen Peroxide Topical Solution (NSN 6505001538480)The contract requires the manufacture and supply of a 3% Hydrogen Peroxide Topical Solution designated by NSN 6505001538480, to be produced and delivered in full compliance with FDA, OSHA, and military labeling standards. The product must be delivered to Camp Beauregard, Louisiana, no later than 20 days after order placement, ensuring timely availability for medical use. The solicitation is issued under the Department of Defense’s Medical Supply Chain PHSA and is classified as a subcontract, with the NAICS code 325412 indicating pharmaceutical and biological product manufacturing. The response deadline is set for July 28, 2026, and the place of performance is listed as Morrisville, North Carolina, with a zip code of 27560-0000, suggesting the supplier may be expected to maintain operations or distribution from that location despite the final delivery destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Manufacture and Supply of Chlorine Test Tablets (DPD NO. 1R)The contract calls for the manufacture and supply of chlorine test tablets that meet FDA compliance standards and are formulated to DPD NO. 1R specifications, ensuring accurate and reliable chlorine detection in water testing applications. The tablets must have a shelf life of 36 months and undergo rigorous batch testing to guarantee consistency, potency, and adherence to technical requirements. All products must be packaged in units of 100 tablets, with packaging designed to maintain stability and integrity throughout storage and distribution. The contract is issued as a subcontract under the Department of Defense’s Medical Supply Chain MD SURG FSF, with performance required at a designated location in Hampton, Virginia, zip code 23665-2040. The solicitation was posted on July 22, 2026, and responses are due by July 28, 2026, providing a limited window for qualified vendors to submit proposals. The NAICS code 325412 indicates the work falls under pharmaceutical and medicine manufacturing, emphasizing the need for production in a controlled environment that supports medical-grade quality assurance. The procurement is part of a broader effort to ensure reliable water safety monitoring capabilities within Department of Defense medical and field operations.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Chloride Quantab Test Strips (High Range)The contract is for the procurement and delivery of high-range chloride test strips capable of measuring concentrations between 300 and 6000 mg/L, packaged in bottles containing 40 strips each. All products must fully comply with DLA medical standards governing packaging, labeling, and shelf life to ensure reliability and safety in medical supply chain applications. The solicitation is classified as a subcontract under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF under the Department of Defense. Performance is required at the designated location in Hampton, Virginia, with a zip code of 23665-2040. The opportunity was posted on July 22, 2026, and responses are due by July 28, 2026, with all submissions expected to meet the technical and regulatory requirements outlined by the agency.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

ZINC OXIDE OINTMENTZinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, is provided in collapsible tubes of 28.35 grams, with the unit of issue designated as a tube (TU). The product is regulated by the FDA and must comply with strict technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, including packaging standards under MIL-STD-129 and commercial packaging per ASTM D3951 when non-hazardous, with DLA requirements superseding all other standards. Labeling must adhere to the latest Medical Marking Standard No. 1, and shelf life is fixed at 36 months without extension. Storage requires controlled room temperature not exceeding 30°C (86°F). The ointment is supplied by DYNAREX CORP under NDC 67777-0223-11 and part number 1190, with traceable shipping mandated and parcel post prohibited. Two delivery lines are specified: three tubes to Morrisville, NC with a July 24, 2026 delivery deadline and six tubes to Fort Bragg, NC with a July 27, 2026 deadline, both delivered FOB destination with zero quantity variance permitted. Inspection and acceptance occur at the delivery point, and packaging must meet DLA's RP001 packaging and palletization requirements. All shipments must include government-identifying information per contract specifications and be tracked through authenticated logistics channels.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MULTIPLE ELECTROLYTThe contract specifies the procurement of Multiple Electrolytes Injection, Type 1, USP, in 500 mL bags, packaged in units of 24 per package, with a required shelf life of 18 months. No more than three months may have elapsed between the date of manufacture and the date of delivery to the government. The product is regulated by the FDA and must meet all applicable technical and quality requirements as defined in the DLA Master List of Technical and Quality Requirements, with packaging and marking strictly compliant with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a suitable container to prevent damage, and shipping containers must ensure safe, low-cost delivery to the point of delivery at Fort Bliss, Texas, with inspection and acceptance occurring at the destination. The item is identified by NSN 6505-01-462-5414 and manufacturer part number NDC00338-0221-03, produced by Baxter Healthcare Corp. The contract requires delivery within 20 days under FOB destination terms with zero variance allowed in quantity. The solicitation is issued under SPE2DP-26-T-4243 with a response deadline in July 2026, and the unit of issue is PG (package of 24), aligned to the DoD authorized unit. Additional provisions include handling of covered defense information and compliance with DLA’s packaging and labeling standards for medical acquisitions.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

FLUCONAZOLE TABLETSFluconazole Tablets 150 mg are supplied in individually sealed blister strips containing 12 tablets per strip, with the unit of issue defined as a package. The product must have a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of delivery to the government. Packaging must comply with commercial standards and be designed to protect the contents from damage or breakage, with exterior shipping containers suitable for safe transport at the lowest possible freight rate. All items must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and mercury or mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the supply except under specific exceptions for functional components like batteries or instruments, which must meet additional containment and shockproof requirements. The National Stock Number is 6505013953039, and the contract is issued under solicitation SPE2DP-26-T-4241 with delivery required FOB destination within 20 days. The quantity ordered is one package with zero variance allowed, and inspection and acceptance occur at the delivery point. The manufacturer identified is Golden State Medical Supply, Inc. with NDC 51407-0426-12, and ANIP Acquisition Co with NDC 62559-0992-12. Applicable technical and quality requirements are referenced from the DLA Master List, and the contract falls under the NAICS code 325412 for pharmaceutical manufacturing.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DIBUCAINE OINTMENTDIBUCAINE OINTMENT USP, containing 1 percent dibucaine as the active ingredient, is supplied in a collapsible tube with a rectal applicator and is intended for rectal administration only, classified for external use. Each unit of issue is a single package containing one ounce or 28 grams of the ointment, with a non-extendable shelf life of 36 months and storage requirements between 15 and 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is FDA-regulated and must comply with the DLA Master List of Technical and Quality Requirements, including MIL-STD-129 for marking and labeling, and packaging must adhere to RP001 for DLA procurement standards, with materials either packaged per IP025 if hazardous or ASTM D3951 if not, prioritizing DLA specifications over commercial standards. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, with a unit of issue in packages and quantity per unit pack of one. The contract SPE2DP-26-T-4234 specifies four separate line items totaling 11 packages, each priced at $2.00, with delivery due within 20 days of order, FOB destination, zero quantity variance allowed, and inspection and acceptance occurring at the delivery point. Shipments are directed to four distinct U.S. Navy vessel addresses in FPO locations, with explicit instructions to avoid parcel post and use only traceable freight methods via VSM. Required delivery dates span from May 29, 2026, to July 24, 2026, with specific RDD codes and project identifiers linked to each delivery. The product must be procured from the HARVARD DRUG GROUP, L.L.C., and all packaging, labeling, and shipping must strictly follow DLA technical and quality directives, including medical marking standards and palletization requirements, ensuring full compliance with federal procurement protocols.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM CHLORIDE INJECTSodium Chloride 0.9% Injection, USP, in 250 mL bags, is being procured under solicitation SPE2DP-26-T-4240 with a unit of issue defined as a PG representing 24 bags, totaling one unit. The item is regulated by the FDA and must comply with strict packaging and marking standards as outlined in Medical Marking Standard No. 1, superseding MIL-STD-129; all units must be sealed in commercial containers that protect against damage and be packed in shipping containers suitable for safe delivery at the lowest cost to Fort Bliss, Texas, under FOB destination terms. The product has a non-extendable shelf life of 24 months and requires storage at room temperature of 25°C, with brief exposure up to 40°C permitted without compromising integrity. Multiple manufacturers and distributors are listed with their respective part numbers, including B. Braun Medical Inc., Trillamed LLC, and Cardinal Health, all producing the same NDC 00264-7800-20 formulation. The contract requires strict adherence to DLA’s Technical and Quality Requirements referenced in the Master List, and all supplies must be delivered within 20 days of award with no variance allowed in quantity. The solicitation closed on July 28, 2026, and is managed by the Department of Defense’s Medical Supply Chain under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ANESTHESIA SET, EPIDURAThe anesthesia set is an epidural kit equipped with a 20-gauge catheter and a 17-gauge Tuohy Schliff winged needle, containing a total of 29 components per package. Each unit of issue is a package containing ten individual sets, and all items must have a shelf life of twelve months from the date of manufacture. No more than two months may elapse between the date of manufacture and the date of delivery to the government to ensure product freshness and safety. The product is identified by NSN 6515-01-323-6531 and is required in a quantity of one package under purchase request 7017577639. All bids must specify the source and part number of the supplied item. The contract is governed by technical and quality requirements from the DLA Master List, with compliance determined by the revision in effect as of the solicitation issue date or award date. Packaging must meet DLA requirements, and any non-accepted supplies must have government identification removed prior to return. The solicitation number is SPE2DS-26-T-260Y, issued on July 22, 2026, with responses due by July 28, 2026. The place of performance is JBER, Alaska, 99506-4400, and the point of contact is James Burke, reachable via email or phone provided. The National Institute of Standards and Technology classification code is 325412, indicating medical device manufacturing. Delivery is required within five days of award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

FLUORESCEIN SODIUM OPHFluorescein Sodium Ophthalmic Strips, USP, are procured under contract SPE2DP-26-T-4239 with strict packaging and labeling requirements mandated by the Defense Logistics Agency. Each unit consists of 100 individually sealed strips containing 1 mg of fluorescein sodium, packed in commercial containers designed to prevent damage or breakage, with exterior shipping containers meeting carrier standards for safe and cost-effective delivery to the designated destination. All items must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and bear required markings including NSN, manufacturer, CAGE code, manufacture date, expiration date, contract number, and lot number. The product has a non-extendable shelf life of 36 months classified as a TYPE I (CODE Q) item. Mercury or mercury-containing compounds are prohibited from intentional addition or direct contact with the product except in specified exceptions such as functional components in batteries or instruments, with portable lamps or instruments containing mercury requiring shock-proof construction and secondary containment per NAVSEA 5100-003D. Suppliers must submit Safety Data Sheets (SDS) and Hazard Communication Standard labels compliant with 29 C.F.R. 1910.1200 prior to award, and ensure employee training on the Globally Harmonized System requirements. The item is regulated by the FDA, and buyers must submit referrals through EBS for confirmation. Delivery is FOB destination within 20 days, with zero quantity variance allowed, and inspection and acceptance occur at the delivery point. The unit of issue is one package (PG), representing 100 strips, and procurement is governed by DLA’s technical and quality requirements outlined in their Master List.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROGEN PEROXIDE TOPIHydrogen Peroxide Topical Solution, USP, is being procured as a 3% stabilized topical solution for external use only, with a unit of issue defined as a 473-milliliter bottle (1 pint). The product is regulated by the FDA and must comply with all labeling and marking requirements specified in Medical Marking Standard No. 1, dated February 4, 2013, which supersedes MIL-STD-129. Each unit must be packaged in a sealed commercial container that protects against damage and breakage, with exterior shipping containers suitable for safe transport via common carrier at the lowest cost to the delivery point. Storage instructions require keeping the solution tightly closed at controlled room temperature, protected from freezing and excessive heat, with no shaking of the bottle and a maximum usage duration of one week. The item has a non-extendable shelf life of 24 months as a TYPE I (CODE M) item per RS016 requirements. Suppliers must submit Safety Data Sheets (SDS) and Hazard Communication Standard (HCS) labels compliant with 29 C.F.R. 1910.1200, effective June 1, 2015, and must train employees on these updated safety protocols. The procurement is under solicitation SPE2DP-26-T-4245 with a response deadline of July 28, 2026, and delivery is required FOB destination within 20 days. Quantity is fixed at 3 bottles with zero variance allowed, and the NSN is 6505-00-153-8480. Only approved manufacturers including Cardinal Health, Medline Industries, and McKesson Medical-Surgical are referenced as eligible suppliers. All requisitions under DMLIIS ID 1721935 are canceled without replacement as part of a change in acquisition classification from ACC-L to ACCY.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Hazardous Material Compliance and Safety DataThe contract requires full compliance with hazard communication standards for epinephrine-containing pharmaceuticals, mandating accurate generation of Safety Data Sheets and proper labeling in accordance with OSHA’s 29 CFR 1910.1200 and DFARS requirements. All deliverables must align with federal regulations governing the safe handling, storage, and dissemination of hazardous chemical information, ensuring that personnel and facilities are properly informed of risks associated with these pharmaceuticals. The work is scoped as a subcontract under NAICS code 541620, targeting specialized scientific and technical services related to regulatory compliance and pharmaceutical safety. Performance is to be conducted at Joint Base Elmendorf-Richardson, Alaska, with the solicitation issued by the Department of Defense through the Medical Supply Chain Pharm FSA. Proposals are due by July 28, 2026, and the contracting vehicle is accessible via the DIBBS platform. While no specific set-aside designation is indicated, the requirement emphasizes strict adherence to federal safety protocols and accurate documentation, reflecting the critical nature of hazard communication for life-saving medications in military and defense supply operations.

Environmental Consulting Services

POSTED

DEADLINE

DoD Medical Item Labeling and BarcodingThe contract requires the application of standardized labels and 2D Data Matrix barcodes to medical shipments and unit packs to comply with the Department of Defense’s Medical Marking Standard No. 1, ensuring accurate tracking and logistics across the military supply chain. This work is critical for maintaining visibility and accountability of medical supplies in theater and within domestic logistics networks, with precise adherence to labeling specifications mandated by the DoD. The performance location is specified as JBER, Alaska, with a zip code of 99506-4400, indicating the physical site where labeling and barcoding operations must be executed. This is a subcontract opportunity under NAICS code 323111, which pertains to commercial printing services, and is managed by the Medical Supply Chain Pharm FSA under the Department of Defense. The solicitation was posted on July 22, 2026, with responses due by July 28, 2026, indicating a short window for potential vendors to submit proposals. The contract aims to support defense medical logistics through reliable, compliant marking practices, and all work must align strictly with DoD requirements to ensure seamless integration into existing tracking systems.

Commercial Printing (except Screen and Books)

POSTED

DEADLINE

DoD-Compliant Medical Packaging and PreservationThe contract requires the supply of sealed unit containers and preservation packaging that meet stringent military standards, specifically MIL-STD-2073-1E and the Medical Marking Standard No. 1, to ensure the protection and integrity of medical items throughout transport and long-term storage. All packaging must be designed and manufactured to withstand environmental stresses and maintain sterility, operational readiness, and traceability under Department of Defense protocols. The items are intended for use in critical medical supply chains where failure to comply with specifications could compromise mission readiness and patient safety. This is a subcontract opportunity issued by the Department of Defense under the Medical Supply Chain Pharm FSA, with performance required at JBER, Alaska, 99506-4400. The North American Industry Classification System code 323113 applies, indicating the work involves custom computer programming and related services tied to packaging systems. Respondents must submit proposals by the deadline of July 28, 2026, and all submissions must align precisely with the technical and labeling requirements outlined in the referenced standards. The solicitation is open to qualified subcontractors capable of delivering compliant, high-integrity packaging solutions under strict defense logistics guidelines.

Commercial Screen Printing

POSTED

DEADLINE

Small Business and Socioeconomic Certification SupportThe contract seeks consulting services to assist small businesses in obtaining and maintaining certifications critical for government contracting, including Women-Owned Small Business, Economically Disadvantaged Women-Owned Small Business, Service-Disabled Veteran-Owned Small Business, and HUBZone certifications, as well as ensuring compliance with the nonmanufacturer rule. These services are essential for businesses aiming to compete for federal procurement opportunities, particularly within the Department of Defense, and require expert guidance to navigate complex eligibility criteria, documentation, and ongoing compliance requirements. The work must be performed in Morrisville, North Carolina, with a response deadline of July 28, 2026, and is structured as a subcontract under NAICS code 541611 for management consulting services. The agency responsible is the Medical Supply Chain Pharm FSA under the Department of Defense, and the opportunity is accessible via the DIBBS platform.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Packaging, Marking, and Shipping Compliance (MIL-STD-129)The contract requires full compliance with MIL-STD-129 and MMS No. 1 standards for the proper packaging, labeling, and marking of all government-bound shipments, ensuring alignment with Department of Defense specifications for military logistics. All items must be prepared and documented to meet exacting military requirements for identification, tracking, and handling during transport. The contractor is responsible for coordinating FOB Destination delivery terms, meaning title and risk transfer to the government only upon arrival at the designated destination, and must provide full support for WAWF invoicing to facilitate accurate and timely payment processing through the Department of Defense's electronic system. This is a subcontract solicitation issued under NAICS code 561910, focused on administrative and support services, with a performance location in Morrisville, North Carolina, and a strict response deadline of July 28, 2026. The contracting authority is the Medical Supply Chain Pharm FSA under the Department of Defense, and the work involves direct support of military medical logistics infrastructure. Compliance with all technical and procedural mandates is non-negotiable, and failure to meet MIL-STD-129 or WAWF requirements may result in rejection of deliveries or payment delays.

Packaging and Labeling Services

POSTED

DEADLINE

Regulatory Compliance & Labeling Services for Hazardous MaterialsThe contract requires the provision of OSHA-compliant hazard labels and Safety Data Sheets for Hydrogen Peroxide shipments, ensuring full adherence to federal regulatory standards. Compliance must align with DFARS 252.223-7001, which mandates specific safety and handling documentation for hazardous materials within the Department of Defense supply chain, while also recognizing applicable FDA exemptions that may apply to pharmaceutical-grade Hydrogen Peroxide. The deliverables must accurately reflect the chemical’s properties, hazards, and emergency response protocols to meet both transportation safety requirements and defense procurement specifications. This subcontract is issued under NAICS code 541690 for other scientific and technical consulting services and is targeted for performance in Morrisville, North Carolina, with a response deadline of July 28, 2026. The contract is managed by the Department of Defense through the Medical Supply Chain Pharm FSA, indicating the materials will support defense-related medical or pharmaceutical logistics. All labeling and SDS documentation must be precise, up-to-date, and verified to avoid non-compliance penalties, and the vendor is expected to maintain rigorous quality control throughout the delivery process to ensure seamless integration into DoD hazardous material handling procedures.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

ALBUTEROL INHALATIOAlbuterol Inhalation Aerosol is a pressurized aluminum canister containing 60 actuations, each delivering 108 micrograms of albuterol sulfate, equivalent to 90 micrograms of albuterol base, via a plastic actuator with a strapcap and integrated counter. The product is prescribed for oral inhalation only and is classified as an institutional pack with a net canister weight of 8 grams. It must be stored at 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F), and must always be kept with the mouthpiece down. The inhaler must be shaken well before each use and brought to room temperature prior to administration for optimal performance. The item has a non-extendable shelf life of 18 months, and at the time of receipt by the first government activity, it must have a minimum of 15 months of remaining shelf life. The product is hazardous due to its pressurized contents and flammable characteristics, and it must not be punctured, exposed to temperatures above 120°F, or disposed of in fire or incinerators. Packaging must comply with hazardous materials regulations including 49 CFR and ICAO standards, and a current Material Safety Data Sheet (MSDS) must accompany each shipment and be submitted via DLA’s designated email. Labeling and marking must adhere to SPE2DP-26-T-4242 and Medical Marking Standard No. 1C. The item is regulated by the FDA, and procurement requires referral confirmation through EBS. Packaging and technical requirements are governed by DLA specifications, including RD003, RA001, and RP001, and the NSN is 6505-01-649-7928. The purchase request is for 10 units with delivery expected within 20 days.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets 100mg are procured under solicitation SPE2DP-26-T-4238 for acute treatment of migraine with or without aura in adults. The product must be supplied in bottles of nine tablets, stored at 20 to 25°C (68 to 77°F), protected from light, and adhere to a strict 24-month non-extendable shelf life as a Type I (Code M) medical item. Packaging and marking must comply with MIL-STD-2073-1E, MIL-STD-129, and DLA’s Medical Marking Standard No. 1, with palletization governed by DLA Packaging Requirements. The item is subject to FDA regulation and requires referral through EBS for confirmation. Two contract line items are listed: one for one bottle and another for five bottles, both with identical specifications, delivered FOB destination within five days, with no variance in quantity allowed. Delivery is directed to JBER, Alaska, with designated shipping and parcel post addresses provided. The required delivery date is July 24, 2026, and the contract includes detailed logistics codes, unit of issue references, and procurement identifiers. Manufacturer identifiers include NDC codes for Mylan Pharmaceuticals Inc and Golden State Medical Supply, Inc., and all technical and quality requirements referenced must align with the DLA Master List at the time of solicitation or award.

Medicinal and Botanical Manufacturing

POSTED

DEADLINE